555 related articles for article (PubMed ID: 29892745)
1. Bifidobacteria attenuate the development of metabolic disorders, with inter- and intra-species differences.
Zhu G; Ma F; Wang G; Wang Y; Zhao J; Zhang H; Chen W
Food Funct; 2018 Jun; 9(6):3509-3522. PubMed ID: 29892745
[TBL] [Abstract][Full Text] [Related]
2.
Wang G; Zhu G; Chen C; Zheng Y; Ma F; Zhao J; Lee YK; Zhang H; Chen W
Benef Microbes; 2021 Jun; 12(3):267-281. PubMed ID: 34109894
[TBL] [Abstract][Full Text] [Related]
3.
Wang B; Kong Q; Cui S; Li X; Gu Z; Zhao J; Zhang H; Chen W; Wang G
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801119
[TBL] [Abstract][Full Text] [Related]
4. Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.
Salazar N; Binetti A; Gueimonde M; Alonso A; Garrido P; González del Rey C; González C; Ruas-Madiedo P; de los Reyes-Gavilán CG
Int J Food Microbiol; 2011 Jan; 144(3):342-51. PubMed ID: 21078530
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary architecture of the infant-adapted group of Bifidobacterium species associated with the probiotic function.
Kwak MJ; Kwon SK; Yoon JK; Song JY; Seo JG; Chung MJ; Kim JF
Syst Appl Microbiol; 2016 Oct; 39(7):429-439. PubMed ID: 27524178
[TBL] [Abstract][Full Text] [Related]
6. Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration.
Ishizeki S; Sugita M; Takata M; Yaeshima T
Anaerobe; 2013 Oct; 23():38-44. PubMed ID: 23988359
[TBL] [Abstract][Full Text] [Related]
7. Bifidobacterial strains shared by mother and child as source of probiotics.
Peirotén A; Arqués JL; Medina M; Rodríguez-Mínguez E
Benef Microbes; 2018 Feb; 9(2):231-238. PubMed ID: 29488411
[TBL] [Abstract][Full Text] [Related]
8. Tolerance of Bifidobacterium human isolates to bile, acid and oxygen.
Andriantsoanirina V; Allano S; Butel MJ; Aires J
Anaerobe; 2013 Jun; 21():39-42. PubMed ID: 23598280
[TBL] [Abstract][Full Text] [Related]
9. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii.
Ramirez-Farias C; Slezak K; Fuller Z; Duncan A; Holtrop G; Louis P
Br J Nutr; 2009 Feb; 101(4):541-50. PubMed ID: 18590586
[TBL] [Abstract][Full Text] [Related]
10. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
[TBL] [Abstract][Full Text] [Related]
11. Beneficial Effects of Non-Encapsulated or Encapsulated Probiotic Supplementation on Microbiota Composition, Intestinal Barrier Functions, Inflammatory Profiles, and Glucose Tolerance in High Fat Fed Rats.
Lee S; Kirkland R; Grunewald ZI; Sun Q; Wicker L; de La Serre CB
Nutrients; 2019 Aug; 11(9):. PubMed ID: 31443365
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria.
Bordoni A; Amaretti A; Leonardi A; Boschetti E; Danesi F; Matteuzzi D; Roncaglia L; Raimondi S; Rossi M
Appl Microbiol Biotechnol; 2013 Sep; 97(18):8273-81. PubMed ID: 23872958
[TBL] [Abstract][Full Text] [Related]
13. N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice.
Zheng J; Yuan X; Zhang C; Jia P; Jiao S; Zhao X; Yin H; Du Y; Liu H
J Diabetes; 2019 Jan; 11(1):32-45. PubMed ID: 29845722
[TBL] [Abstract][Full Text] [Related]
14. Age-Related Changes in the Composition of Gut Bifidobacterium Species.
Kato K; Odamaki T; Mitsuyama E; Sugahara H; Xiao JZ; Osawa R
Curr Microbiol; 2017 Aug; 74(8):987-995. PubMed ID: 28593350
[TBL] [Abstract][Full Text] [Related]
15. Western diets, gut dysbiosis, and metabolic diseases: Are they linked?
Martinez KB; Leone V; Chang EB
Gut Microbes; 2017 Mar; 8(2):130-142. PubMed ID: 28059614
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns.
Aloisio I; Santini C; Biavati B; Dinelli G; Cencič A; Chingwaru W; Mogna L; Di Gioia D
Appl Microbiol Biotechnol; 2012 Dec; 96(6):1561-76. PubMed ID: 22588500
[TBL] [Abstract][Full Text] [Related]
17. Interplay of Gut Microbiota, Probiotics in Obesity: A Review.
Pothuraju R; Sharma RK
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):212-220. PubMed ID: 29384067
[TBL] [Abstract][Full Text] [Related]
18. Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants.
Di Gioia D; Aloisio I; Mazzola G; Biavati B
Appl Microbiol Biotechnol; 2014 Jan; 98(2):563-77. PubMed ID: 24287935
[TBL] [Abstract][Full Text] [Related]
19. [Species characteristic and factors of persistence of gut bifidoflora during healthy state and dysbiosis].
Ivanova EV; Perunova NB; Valyshev AV; Valysheva IV; Bukharin OV
Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):89-93. PubMed ID: 19462518
[TBL] [Abstract][Full Text] [Related]
20. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
